What Researchers Did
Researchers prospectively investigated the safety and efficacy of hyperbaric oxygen as the primary and sole treatment for severe radiation-induced haemorrhagic cystitis in 38 patients.
What They Found
All 38 patients completed hyperbaric oxygen therapy without complications, with a mean follow-up of 29.33 months. The study reported an 86.8% complete response rate and a 13.2% partial response rate, with a median of 33 sessions needed for success. All 33 patients achieving complete response initiated therapy within 6 months of haematuria onset.
What This Means for Canadian Patients
For Canadian patients experiencing severe radiation-induced haemorrhagic cystitis, hyperbaric oxygen therapy could be a safe and effective primary treatment option. Early initiation of this therapy may improve outcomes, potentially reducing the need for more invasive procedures like surgery.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A limitation of this study is its relatively small sample size and the absence of a control group, which could limit the generalizability of the findings.